From the recruitment perspective, our observed migratory advantage without TGF-β1 in high SMAD3 fibroblasts is consistent with a larger recruitment of TAFs in ADC patients selectively at early stages, when active TGF-β1 is expected to be low [18]. The gene discussed is SMAD3; the disease is AIDS dementia complex.